Quaker Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$46.1K Hold
291
0.01% 172
2026
Q1
$37.2K Buy
291
+30
+11% +$3.75K 0.01% 192
2025
Q4
$31.8K Buy
261
+11
+4% +$1.26K 0.01% 211
2025
Q3
$25.1K Sell
250
-373
-60% -$33.6K 0.01% 224
2025
Q2
$51.7K Buy
+623
New +$49.7K 0.02% 159
2024
Q3
$4.78M Buy
+48,406
New +$4.76M 1.75% 19

Other funds holding XBI

Quaker Wealth Management's XBI Position: Q2 2026 in Review

Quaker Wealth Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 291 shares worth $46.1K. The position accounts for 0.01% of the portfolio, ranked #172.

Quaker Wealth Management first reported a position in XBI in Q3 2024 and has held it in 6 quarters since. The position peaked at $4.78M in Q3 2024. 260 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Quaker Wealth Management held 291 shares of State Street SPDR S&P Biotech ETF worth $46.1K as of Q2 2026.
  • Quaker Wealth Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up 0.01% of Quaker Wealth Management's portfolio in Q2 2026, its #172 holding.
  • Quaker Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2024 and has held it in 6 quarters since.
  • Quaker Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $4.78M in Q3 2024.
  • 260 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Quaker Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.